Skip to main content

Table 4 XYZ and FSN classification and cross-tabulation of pharmaceuticals in selected health centers and hospitals in Hadiya zone, Ethiopia

From: Matrix analyses of pharmaceutical products for the years 2017 to 2019 among public health facilities in Hadiya zone, Ethiopia: a cross-sectional descriptive study

2017

2018

2019

Class

Frequency

No. of

Items (%)

Total value in ETB

%-agea

No. of

Items (%)

Total value in ETB

%-age

No. of

Items (%)

Total value in ETB

%-age

F

 > 15

146 (45.5)

16,705,873.4

81.4

168 (46.5)

19,265,277.0

87.1

187 (46.5)

21,328,407.3

90.1

S

5–15

90 (28.0)

2,655,710.8

12.0

167 (46.3)

2,721,620.7

12.3

198 (49.3)

2,248,069.7

9.5

N

 < 5

85 (26.5)

1,152,905.6

5.6

26 (7.2)

131,904.6

0.6

17 (4.2)

102,508.0

0.4

Total

 

321(100)

20,514,489.7

100

361 (100)

22,118,802.3

100

402 (100)

23,678,985.0

100

X

 

51 (17.3)

11,004,295.8

70.1

64 (23.3)

9,238,916.9

70.3

81 (26.7)

9,448,323.2

70.2

Y

 

98 (33.2)

3,195,536.1

20.4

95 (34.7)

2,659,802.3

20.2

96 (31.7)

2,720,285.3

20.2

Z

 

146 (49.5)

1,491,551.2

9.5

115 (42.0)

1,253,713.6

9.5

126 (41.6)

1,288,774.3

9.6

Total

 

295 (100)

15,691,383.1

100

274 (100)

13,152,432.8

100

303 (100)

13,457,382.8

100

XYZ-FSN coupling

XF

 

39 (13.2)

9,409,603.2

60.0

47 (17.2)

7,983,894.4

60.7

62 (20.5)

8,163,335.0

60.7

YF

 

46 (15.6)

1,518,335.6

9.7

50 (18.2)

1,417,847.7

10.8

50 (16.5)

1,413,860.8

10.5

ZF

 

31 (10.5)

336,892.9

2.2

36 (13.1)

416,382.3

3.2

34 (11.2)

391,942.1

2.9

XS

 

9 (3.1)

1,046,564.2

6.7

9 (3.3)

512,304

3.9

10 (3.3)

520,144.7

3.9

XN

 

5 (1.7)

665,345.7

4.2

9 (3.3)

782,256

5.9

11 (3.6)

845,763.1

6.3

YS

 

14 (4.7)

423,743.3

2.7

24 (8.8)

664,951.8

5.1

29 (9.6)

774,705.4

5.8

ZS

 

36 (12.2)

405,155.8

2.6

38 (13.9)

399,560.8

3

46 (15.2)

451,216.1

3.4

YN

 

36 (12.2)

1,136,239.9

7.2

20 (7.3)

537,465.3

4.1

16 (5.3)

467,036.1

3.5

ZN

 

79 (26.8)

749,502.5

4.7

41 (14.9)

437,770.5

3.3

45 (14.9)

429,379.4

3.2

Total

 

295(100)

15,691,383.1

100

274 (100)

13,152,432.8

100

303 (100)

13,457,382.8

100

I

 

130(44.1)

12,976,741.6

82.8

151(55.1)

11,112,684.4

84.5

167(55.1)

11,335,045.7

84.3

II

 

86(29.2)

1,965,139.0

12.5

82(30)

1,601,977.9

12.2

91(30.1)

1,692,957.6

12.7

III

 

79(26.7)

749,502.5

4.7

41(14.9)

437,770.5

3.3

45(14.8)

429,379.4

3.2

  1. apercentage